Opinion

Video

Expert Perspective on the Expanding Treatment Landscape in mCRPC

Key opinion leaders explore the expanding treament landscape for mCRPC.

  • Given the evolution/expansion of the prostate cancer treatment landscape for metastatic castration-resistant prostate cancer (mCRPC), can you discuss key factors that shape your treatment approach?
  • How do patient characteristics such as age, performance status, and comorbidities influence that decision?
Related Videos
Alicia Morgans, MD, MPH, answers a question during a Zoom video interview
2 experts in this video
2 experts in this video
2 experts in this video
2 experts in this video
Related Content
© 2025 MJH Life Sciences

All rights reserved.